Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura

  1. González-Lois, C.
  2. Ballestín, C.
  3. Sotelo, M.T.
  4. López-Ríos, F.
  5. García-Prats, M.D.
  6. Villena, V.
Revue:
Histopathology

ISSN: 0309-0167

Année de publication: 2001

Volumen: 38

Número: 6

Pages: 528-534

Type: Article

DOI: 10.1046/J.1365-2559.2001.01157.X GOOGLE SCHOLAR

Objectifs de Développement Durable